285 related articles for article (PubMed ID: 33280640)
1. Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review.
Nanjappa MS; Voyiaziakis E; Pradhan B; Mannekote Thippaiah S
CNS Spectr; 2022 Jun; 27(3):290-297. PubMed ID: 33280640
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
3. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
4. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
6. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
Park P; Caballero J; Omidian H
Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
[TBL] [Abstract][Full Text] [Related]
8. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
9. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
12. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
13. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
14. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
16. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
Rozner L; Aisenberg Romano G; Klieger C; Bloch M
Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
[TBL] [Abstract][Full Text] [Related]
17. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
Sobieraj DM; Martinez BK; Hernandez AV; Coleman CI; Ross JS; Berg KM; Steffens DC; Baker WL
J Am Geriatr Soc; 2019 Aug; 67(8):1571-1581. PubMed ID: 31140587
[TBL] [Abstract][Full Text] [Related]
18. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Dell'Osso B; Nestadt G; Allen A; Hollander E
J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]